Full Text
The Full Text of this article is available as a PDF (166.7 KB).
Figure 1 .
Omeprazole versus cimetidine and omeprazole versus placebo in uninvestigated dyspeptic patients in primary care.10 APT, all patients treated.
Figure 2 .
OMEGA study: results at two and four weeks.13 APT, all patients treated.
Figure 3 .
COMPETE study: results at four and 16 weeks.14
Figure 4 .
Quality of life before and after treatment of patients with uninvestigated dyspepsia managed in primary care.13 PGWB, psychological general well being index; GORD, gastro-oesophageal reflux disease.
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bytzer P., Hansen J. M., Schaffalitzky de Muckadell O. B. Empirical H2-blocker therapy or prompt endoscopy in management of dyspepsia. Lancet. 1994 Apr 2;343(8901):811–816. doi: 10.1016/s0140-6736(94)92023-0. [DOI] [PubMed] [Google Scholar]
- Goulston K. J., Dent O. F., Mant A., Logan J., Ngu M. Use of H2-receptor antagonists in patients with dyspepsia and heartburn: a cost comparison. Med J Aust. 1991 Jul 1;155(1):20–26. doi: 10.5694/j.1326-5377.1991.tb116372.x. [DOI] [PubMed] [Google Scholar]
- Goves J., Oldring J. K., Kerr D., Dallara R. G., Roffe E. J., Powell J. A., Taylor M. D. First line treatment with omeprazole provides an effective and superior alternative strategy in the management of dyspepsia compared to antacid/alginate liquid: a multicentre study in general practice. Aliment Pharmacol Ther. 1998 Feb;12(2):147–157. doi: 10.1046/j.1365-2036.1998.0284f.x. [DOI] [PubMed] [Google Scholar]
- Jones R. H., Baxter G. Lansoprazole 30 mg daily versus ranitidine 150 mg b.d. in the treatment of acid-related dyspepsia in general practice. Aliment Pharmacol Ther. 1997 Jun;11(3):541–546. doi: 10.1046/j.1365-2036.1997.00179.x. [DOI] [PubMed] [Google Scholar]
- Jones R. H., Lydeard S. E., Hobbs F. D., Kenkre J. E., Williams E. I., Jones S. J., Repper J. A., Caldow J. L., Dunwoodie W. M., Bottomley J. M. Dyspepsia in England and Scotland. Gut. 1990 Apr;31(4):401–405. doi: 10.1136/gut.31.4.401. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Jones R., Crouch S. L. Low-dose lansoprazole provides greater relief of heartburn and epigastric pain than low-dose omeprazole in patients with acid-related dyspepsia. Aliment Pharmacol Ther. 1999 Mar;13(3):413–419. doi: 10.1046/j.1365-2036.1999.00455.x. [DOI] [PubMed] [Google Scholar]
- Jones R., Lydeard S. Dyspepsia in the community: a follow-up study. Br J Clin Pract. 1992 Summer;46(2):95–97. [PubMed] [Google Scholar]
- Jones R. Self-care and primary care of dyspepsia: a review. Fam Pract. 1987 Mar;4(1):68–77. doi: 10.1093/fampra/4.1.68. [DOI] [PubMed] [Google Scholar]
- Jones R., Tait C., Sladen G., Weston-Baker J. A trial of a test-and-treat strategy for Helicobacter pylori positive dyspeptic patients in general practice. Int J Clin Pract. 1999 Sep;53(6):413–416. [PubMed] [Google Scholar]
- Lydeard S., Jones R. Factors affecting the decision to consult with dyspepsia: comparison of consulters and non-consulters. J R Coll Gen Pract. 1989 Dec;39(329):495–498. [PMC free article] [PubMed] [Google Scholar]
- Mason I., Millar L. J., Sheikh R. R., Evans W. M., Todd P. L., Turbitt M. L., Taylor M. D. The management of acid-related dyspepsia in general practice: a comparison of an omeprazole versus an antacid-alginate/ranitidine management strategy. Compete Research Group [corrected]. Aliment Pharmacol Ther. 1998 Mar;12(3):263–271. doi: 10.1046/j.1365-2036.1998.00282.x. [DOI] [PubMed] [Google Scholar]
- Patel P., Khulusi S., Mendall M. A., Lloyd R., Jazrawi R., Maxwell J. D., Northfield T. C. Prospective screening of dyspeptic patients by Helicobacter pylori serology. Lancet. 1995 Nov 18;346(8986):1315–1318. doi: 10.1016/s0140-6736(95)92340-3. [DOI] [PubMed] [Google Scholar]